Boehringer, Alpha to locally make type 2 diabetes medicines

Boehringer Ingelheim, a leading pharmaceutical firm, has transferred of manufacturing operations of one of its innovative medicines for the treatment of type 2 diabetes to Alpha Pharma in Saudi Arabia.

Related Keywords

Saudi Arabia ,Jeddah ,Makkah ,Saudi ,Boehringer Ingelhiem ,Saleh Al Khabti ,Alpha Pharma ,Shaikh Yaser Al Naghi ,Boehringer Ingelheim ,Waleed Mashak ,Ministry Of Investment ,Ministry Of Industry ,Government Procurement Authority ,Mineral Resources ,Local Content ,General Manager ,Human Pharma ,Yaser Al Naghi ,Cigalah Healthcare ,Deputy Minister ,Investment Transactions ,Tradearabia ,Rade Arabia ,Iddle East Trade News ,Cc Business News ,Ndustry News ,Trade News ,Usiness Directory ,Enders ,Roject News ,Remium Content ,